- Finance, Insurance & Real Estate›
- Banks & Financial Services›
NASDAQ biotech index closing values 2010-2017
NASDAQ biotech index closing values 2010-2017
Value of the NASDAQ biotech Index from 2010 to 2017
by M. Szmigiera,
last edited
Feb 1, 2019
This statistic presents the year-end closing values of the NASDAQ biotech Index from 2010 to 2017. The value of NASDAQ biotech Index amounted to 3,357 points in 2017.
Value of the NASDAQ biotech Index from 2010 to 2017
Loading statistic...
| Year | Index value |
|---|---|
| 2017 | 3,357 |
| 2016 | 2,773 |
| 2015 | 3,540 |
| 2014 | 3,178 |
| 2013 | 2,370 |
| 2012 | 1,431 |
| 2010 | 970 |
| Year | Index value |
|---|---|
| 2017 | 3,357 |
| 2016 | 2,773 |
| 2015 | 3,540 |
| 2014 | 3,178 |
| 2013 | 2,370 |
| 2012 | 1,431 |
| 2010 | 970 |
© Statista 2019
About this statistic
Sources: Global Financial Data; ProQuest
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by M. Szmigiera,
last edited
Feb 1, 2019
This statistic presents the year-end closing values of the NASDAQ biotech Index from 2010 to 2017. The value of NASDAQ biotech Index amounted to 3,357 points in 2017.
- Sources
- Global Financial Data; ProQuest
- Show further sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- December 2018
- Region
- United States
- Survey time period
- 2010 to 2017
- Special properties
- year end closing values.
- Supplementary notes
- The source states: "Oct. 29, 1993 = 200".
Source
- Sources
- Global Financial Data; ProQuest
- Show further sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- December 2018
More information
- Region
- United States
- Survey time period
- 2010 to 2017
- Special properties
- year end closing values.
- Supplementary notes
- The source states: "Oct. 29, 1993 = 200".
Other statistics on the topic
Biotechnology industry
+Farming
Percentage of genetically modified crops in the U.S. by type 2018
+Pharmaceutical Products & Market
Gross profit margin of select U.S. biotech and drugs companies Q3 2018
+Pharmaceutical Products & Market
Top global biotech companies based on market capitalization 2018
+Pharmaceutical Products & Market
Amgen's top product revenues 2016-2018
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Biotech industry
- 90 page/s
- English
- pptx
- Detailed references
Everything On "Biotech industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Biotech industry"
- Global overview
The most important statistics
- Global top 10 companies based on biotech prescription drug revenue in 2018 and 2024 (in billion U.S. dollars)*Global top companies based on biotech prescription drug revenue in 2018 and 2024
- Top global biotechnology companies based on market capitalization as of 2018 (in billion U.S. dollars)Top global biotech companies based on market capitalization 2018
- Select top global biotechnology companies' R&D expenditure in 2017 (in million U.S. dollars)Top global biotech companies - R&D expenditure 2017
- Selected top biotechnology companies based on number of employees worldwide in 2017Top global biotech companies based on number of employees 2017
- Value of the NASDAQ biotech Index from 2010 to 2017NASDAQ biotech index closing values 2010-2017
- Change in pharmaceutical and biotech industry stock indices worldwide in 2018Change in global biotech-pharma industry stock indices 2018
- U.S. companies
The most important statistics
- Gilead Sciences' revenue from 2006 to 2018 (in million U.S. dollars)Gilead Sciences' revenue 2006-2018
- Top products of Gilead Sciences from 2016 to 2018, based on revenue (in million U.S. dollars)Gilead Sciences' top products based on revenue 2016-2018
- Total revenue of biotech company Amgen from 2004 to 2018 (in million U.S. dollars)Amgen's total revenue 2004-2018
- Revenues of selected Amgen's top products from 2016 to 2018 (in million U.S. dollars)Amgen's top product revenues 2016-2018
- Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)Biogen's revenue and net income 2007-2018
- Biogen's top products from 2016 to 2018, based on revenue (in million U.S. dollars)Biogen's top products based on revenue 2016-2018
- Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016Market cap CAGR of biotech companies in the U.S. 2012-2016
- Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*Pre-commercial biotech companies with large market caps in the U.S. 2017
- Research & development
The most important statistics
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*Top 50 global pharmaceutical and biotech companies by R&D intensity in 2017/2018
- Average cost to bring a pharmaceutical asset to market among large cap biopharma companies between 2010 and 2018 (in billion U.S. dollars)Cost to bring large cap biopharmaceutical assets to market 2010-2018
- Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018 (in billion U.S. dollars)Cost to bring biopharmaceutical assets in mid cap companies to market 2010-2018
- Projected rate of return on biopharmaceutical research and development investments from 2010 to 2017Projected return on biopharma R&D investments U.S. 2010-2017
- Biotech alliances with big up-front payments in the U.S. and Europe in 2016 (in million U.S. dollars)Alliances in U.S. and Europe biotechnology industry with big up-front payments 2016
- Products
The most important statistics
- Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)Global biologics spending 2002-2017
- Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)Top-selling biotech drugs based on revenue 2017
- Number of biopharma medicines in development in the U.S. as of April 2019, by therapeutic category*Pharmaceuticals: biopharma medicines in development in 2019, by category
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Total U.S. pharmaceutical and biotech revenues for products 5 years after launch from 2007 to 2017 (in billion U.S. dollars)Total U.S. pharma and biotech product sales 5 years after launch 2007-2017
- Funding/investment
The most important statistics
- Total biotechnology funding by the National Institutes for Health (NIH) from FY 2013 to FY 2020 (in million U.S. dollars)biotechnology funding by National Institutes for Health 2013-2020
- Bioscience venture capital investments in the U.S. between 2014 and 2017, by sector (in million U.S. dollars)U.S. bioscience venture capital investments by segment 2014-2017
- Biotech/pharmaceutical investments in the legal cannabis industry in the United States from 2015 to 2017 (in million U.S. dollars)*Legal cannabis industry investments on biotech in the U.S. 2015-2017
- Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars)Value of U.S. and EU biotech IPOs, January-October 2017
- Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars)Amount of top U.S. biotech venture financings 2017
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*Capital raised by regenerative medicine companies worldwide 2016-2018
- Biotech in agriculture
The most important statistics
- Acreage of genetically modified crops worldwide from 2003 to 2017 (in million hectares)Acreage of genetically modified crops worldwide 2003-2017
- Acreage of genetically modified crops worldwide from 2015 to 2017, by leading country (in million hectares)*Acreage of genetically modified crops 2015-2017, by country
- Percentage of genetically modified crops in the U.S. in 1997 and 2018, by type (as percent of total acreage)Percentage of genetically modified crops in the U.S. by type 2018
- Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (in million U.S. dollars)*Monsanto's seed and genomics segment net sales 2011-2017
- Sales of Syngenta AG worldwide from 2013 to 2018, by segment (in billion U.S. dollars)Syngenta AG's sales worldwide by segment 2013-2018
- Bayer CropScience's revenue from 2005 to 2018 (in million euros)Bayer CropScience's revenue 2005-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- NASDAQ Bank Index closing values 2010-2017
- NASDAQ transportation Index closing values 2010-2017
- NASDAQ computers Index closing values 2010-2017
- NYSE Composite Index yearly low values 2010-2017
- U.S. dividend yield for S&P 500, 2000-2017
- American Stock Exchange Composite Index year end values 2000-2017
- S&P 500 composite index Earnings Price Ratio 2010-2017
- NASDAQ telecommunications Index closing values 2010-2017
- S&P 400 MidCap index closing value 2010-2017
- NYSE Composite Index yearly high values 2010-2017
- Annual performance of the S&P BSE Sensex Index in India 2010-2018
- Monthly performance of the S&P BSE Sensex Index in India 2017
- Monthly performance of the Nifty 50 Index in India 2017
- Annual performance of the Nifty 50 Index in India 2010-2018
- Total number of IPOs for leading stock exchanges in Europe Q3 2017
- R&D spending on biotech activities made by companies in Spain 2008-2017
- Industry revenue of »research, experimental development on biotechnology« in Denmark 2011-...
- Annual net result of Genmab 2008-2018
- Leading Spanish companies in R&D on biotechnology 2016
- Industry revenue of »research, experimental development on biotechnology« in Finland 2011-...
Studies
- Stock market indices
- The Dow Jones indices
- Stock exchanges
- Mutual funds
- European Responsible Investing Fund Market 2019
- European SRI Study 2018
- World Federation of Exchanges - Annual Report 2013
- European SRI Study 2016
- European SRI Study 2014
- European Responsible Investing Fund Survey 2015
- European Responsible Investing Fund Market 2016
Statistics on "Biotech industry"
- Global top 10 companies based on biotech prescription drug revenue in 2018 and 2024 (in billion U.S. dollars)*
- Top global biotechnology companies based on market capitalization as of 2018 (in billion U.S. dollars)
- Select top global biotechnology companies' R&D expenditure in 2017 (in million U.S. dollars)
- Selected top biotechnology companies based on number of employees worldwide in 2017
- Value of the NASDAQ biotech Index from 2010 to 2017
- Change in pharmaceutical and biotech industry stock indices worldwide in 2018
- Gilead Sciences' revenue from 2006 to 2018 (in million U.S. dollars)
- Top products of Gilead Sciences from 2016 to 2018, based on revenue (in million U.S. dollars)
- Total revenue of biotech company Amgen from 2004 to 2018 (in million U.S. dollars)
- Revenues of selected Amgen's top products from 2016 to 2018 (in million U.S. dollars)
- Biogen's revenue and net income from 2007 to 2018 (in million U.S. dollars)
- Biogen's top products from 2016 to 2018, based on revenue (in million U.S. dollars)
- Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016
- Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*
- Gross profit margin of selected U.S. biotech and drugs companies as of Q3 2018
- Expected top life science startups in the United States in 2019*
- World's top 50 pharmaceutical and biotechnology companies based on R&D intensity in 2017/2018*
- Average cost to bring a pharmaceutical asset to market among large cap biopharma companies between 2010 and 2018 (in billion U.S. dollars)
- Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies in 2010, 2016, 2017, and 2018 (in billion U.S. dollars)
- Projected rate of return on biopharmaceutical research and development investments from 2010 to 2017
- Biotech alliances with big up-front payments in the U.S. and Europe in 2016 (in million U.S. dollars)
- Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)
- Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)
- Number of biopharma medicines in development in the U.S. as of April 2019, by therapeutic category*
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)
- Total U.S. pharmaceutical and biotech revenues for products 5 years after launch from 2007 to 2017 (in billion U.S. dollars)
- Total biotechnology funding by the National Institutes for Health (NIH) from FY 2013 to FY 2020 (in million U.S. dollars)
- Bioscience venture capital investments in the U.S. between 2014 and 2017, by sector (in million U.S. dollars)
- Biotech/pharmaceutical investments in the legal cannabis industry in the United States from 2015 to 2017 (in million U.S. dollars)*
- Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars)
- Value of the top U.S. biotech venture financings in 2017 (in million U.S. dollars)
- Capital raised by regenerative medicine companies worldwide from 2016 to 2018 (in million U.S. dollars)*
- Acreage of genetically modified crops worldwide from 2003 to 2017 (in million hectares)
- Acreage of genetically modified crops worldwide from 2015 to 2017, by leading country (in million hectares)*
- Percentage of genetically modified crops in the U.S. in 1997 and 2018, by type (as percent of total acreage)
- Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (in million U.S. dollars)*
- Sales of Syngenta AG worldwide from 2013 to 2018, by segment (in billion U.S. dollars)
- Bayer CropScience's revenue from 2005 to 2018 (in million euros)
- Value of the NASDAQ Bank Index from 2010 to 2017
- Value of the NASDAQ transportation Index from 2010 to 2017
- Value of the NASDAQ computers Index from 2010 to 2017
- Yearly lows of the NYSE Composite Index from 2010 to 2017
- Standard & Poor's 500 dividend yields in the U.S. from 2000 to 2017 (in percent)
- American Stock Exchange Composite Index year end values from 2000 to 2017
- Earnings Price Ratio of Standard and Poor's 500 composite index from 2010 to 2017
- Value of the NASDAQ telecommunications Index from 2010 to 2017
- Value of the Standard and Poor's 400 MidCap index from 2010 to 2017
- Yearly highs of the NYSE Composite Index from 2010 to 2017
- Average annual performance of the S&P BSE Sensex Index in India from FY 2011 to FY 2018
- Average monthly performance of the S&P BSE Sensex Index in India from April to December 2017
- Average monthly performance of the Nifty 50 Index in India from April to December 2017
- Average annual performance of the Nifty 50 Index in India from FY 2011 to FY 2018
- Total number of initial public offerings (IPOs) for the leading three stock exchanges in Europe as of 3rd quarter 2017
- R&D expenditure on biotechnology-related activities made by companies in Spain from 2008 to 2017 (in thousand euros)
- Industry revenue of »research, experimental development on biotechnology« in Denmark from 2011 to 2023 (in million U.S. Dollars)
- Annual net result of Genmab from 2008 to 2018 (in million DKK)
- Leading companies in research and experimental development on biotechnology in Spain in 2016, based on sales value (in thousand euros)
- Industry revenue of »research, experimental development on biotechnology« in Finland from 2011 to 2023 (in million U.S. Dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.